37 prescribers and one major vision group cautioned following consumer complaints over illegal fees for prescription access. The Federal Trade Commission (FTC) sent warning letters to 37 contact…
Read MorePrescriptions
Federal Agencies Request Public Input on Healthcare Price Transparency
The effort aligns with President Trump’s executive order on healthcare pricing. The Departments of Labor, Health and Human Services (HHS), and the Treasury recently issued a joint Request…
Read MoreFTC Challenges Drug Patents Hindering Generic Competition
The agency renewed efforts to remove over 200 disputed patents from FDA’s Orange Book to promote affordable medication access. The Federal Trade Commission (FTC) recently renewed its challenge…
Read MoreHHS Issues Report from President’s MAHA Commission
The health secretary says policy recommendations will be issued over the next 100 days. The Department of Health and Human Services (HHS) released a preliminary health assessment last…
Read MoreWalgreens Agrees to Settlement Over Illegal Prescription Allegations
The pharmacy was accused of filling “excessive quantities of opioids.” Walgreen Boots Alliance has agreed to an up to $350 million settlement with the Department of Justice (DOJ),…
Read MoreFDA Approves First Treatment for Rare Disease
Ctexli offers hope for patients with a previously untreated metabolic disorder, Cerebrotendinous Xanthomatosis. The U.S. Food and Drug Administration (FDA) has approved Ctexli (chenodiol) as the first treatment…
Read MorePresident Trump’s Administration Frees American Teacher
Marc Fogel, who been convicted in Russia for medical marijuana possession, was swapped for a Russian money launderer. President Donald Trump’s Envoy to the Middle East, Steve Witkoff,…
Read MoreFederal Court Rules in Favor of Generic Drug Competition in Patent Case
The court orders the removal of improper patent listings, clearing the path for lower-cost medications. The Federal Circuit U.S. Court of Appeals recently upheld a lower court’s decision…
Read MoreMedicare Cost for 64 Drugs Decreases
The savings under the Inflation Reduction Act are anticipated to benefit 853,000 enrollees. Starting January 1, 2025, Medicare enrollees will see reduced coinsurance rates for 64 drugs under…
Read MoreJustice Department Sues CVS Over Prescription Metric Boosting
The department claims the practice contributed to the rise in opioid-related deaths. The Department of Justice (DOJ) sued CVS Health last week, alleging that the company knowingly filled…
Read More